Continuing its Israeli merger spree, Covidien announces that it nabbed hernia mesh maker PolyTouch Medical for an undisclosed amount.
Med-tech titan Covidien (NYSE:COV) continued its M&A spree in Israel, picking up hernia mesh maker PolyTouch Medical Ltd.
It's Covidien's 3rd Israeli transaction in Israel since February and its 4th overall.
Covidien beat Wall Street by 2¢ with its latest earnings report, touting sales of $2.95 billion for the 2nd quarter.
Covidien (NYSE:COV) posted healthy growth during its fiscal 2nd quarter, beating Wall Street's estimates and maintaining its guidance for the rest of the year.
The Mansfield, Mass.-based med-tech titan posted sales of $2.95 billion in the 3 months ended March 30, a 5% uptick from the same period last year.
The FDA approves Boston Scientific's Epic self-expanding iliac stent.
Boston Scientific (NYSE:BSX) won pre-market approval from the FDA for its Epic self-expanding iliac stent.
The watchdog agency approved the device for treating de novo or restenotic symptomatic atherosclerotic lesions in the iliac arteries, according to agency documents released today.
The medical technology sector's fortunes this year depend on its ability to navigate the headwinds generated by a host of pressures, but the Dow Jones med-tech index shows that the segment's momentum may be slowing; also, NeuroLogica, Stryker in surgical CT scanner pact; Cardiac Sciences to bow out of Washington; Teleflex expands in Minnesota; Geomagic gets tactile with Sensable buys; and Intuitive Surgical logs yet another 52-week high.
The medical technology sector must face up to a host of pressures if it wants to grow this year, according 1 analyst shop, but the leading med-tech index, the iShares DJ U.S. Medical Devices Index Fund, shows that med-tech's momentum slowed during the first quarter.
Philips CEO Steve Rusckowski gets retrospective, Thoratec's HeartMate II correction becomes a Class I recall and Oridion spikes 70% on Covidien merger news.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
6 of the top 10 medical device makers have no definitive environmental stainability goals and the 4 who do may be missing opportunities to take their strategies outward, according to a Green Research report.
MASSDEVICE ON CALL — A look at the top 10 medical device makers found that more than half had little to no environmental initiatives in place.
In a study conducted by Green Research, the companies with stainability initiatives were:
Covidien continues its buying spree with a deal to acquire Oridion Systems for $300 million in cash, sending Oridion soaring on Wall Street.